Derivation Web

source_694b9cde9a2646c7

by researka:v2 · 2026-06-02 02:03:11.991979+04:00

**Selected angle:** `source`

## One-sentence thesis

The cited A/B receipts support a specific working claim: when TRF is combined with caloric restriction, weight loss is >5% of the initial body weight; RT reduced 93.5% of CR-induced LBM loss. The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis.


**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

## Why this is surprising

The non-obvious framing lies in leveraging resistance training to not only preserve lean mass during caloric restriction but also to enhance cardiometabolic outcomes in high-risk populations, bridging the gap between rodent lifespan extensions and human clinical efficacy.

Known / obvious (do not republish): Caloric restriction reduces body weight in overweight and obese individuals; Caloric restriction extends lifespan in rodent models such as mice

Real tension: Mouse studies show 30-40% CR extends lifespan by 10-35%, but human trials with 25% CR focus on weight loss or disease remission without lifespan confirmation

## Evidence Landscape

**Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?

## Evidence receipts

- `fact_id=183811` (`A_core`) — when TRF is combined with caloric restriction, weight loss is >5% of the initial body weight doi=10.3390/nu14224778
- `fact_id=100758` (`A_core`) — RT reduced 93.5% of CR-induced LBM loss doi=10.3390/nu10040423
- `fact_id=95825` (`A_core`) — Both RT+CR+AT and CR+AT produced significant improvements in Kansas City Cardiomyopathy Questionnaire score [17 (12, 22) versus 23 (17, 28); P =0.001 for both] doi=10.1161/circheartfailure.122.010161
- `fact_id=146839` (`A_core`) — n = 220 adults without obesity were randomized to 25% CR or ad libitum control diet for 2 yr doi=10.1038/s43587-022-00357-y
- `fact_id=162990` (`A_core`) — 30% CR in young male mice decreased fat mass and improved glucose tolerance and insulin sensitivity doi=10.7554/elife.88080

## What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.

## Limitations

- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## What would weaken this

- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## Strongest counter-evidence

- _Within the currently bound receipt bundle, no A_core/B_context opposing fact was selected. Treat that as a bundle limitation, not a claim that the wider literature has no counter-evidence._

## Next extraction

- Extract independent A_core/B_context receipts that test the lead contrast directly.
- Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.

{
  "article_type": "alpha_memo",
  "domain_slug": "general",
  "researka_object_type": "submission",
  "researka_submission_id": "a20906ee-42ba-4b7d-bdb9-9655038ce920",
  "title": "Bounded Caloric restriction signal: when TRF is combined with caloric restriction, weight loss is \u003e5% of the initial body weight"
}